Max Robotics — Global Service Robot Directory + US Certification

About

Christian Tanislav is a urological surgeon and researcher whose work centers on optimizing outcomes in robot-assisted radical prostatectomy (RARP) for prostate cancer. His primary research areas include the impact of patient-specific anatomical and physiological factors—such as prostate volume and body mass index (BMI)—on surgical recovery, as well as the role of neoadjuvant hormonal therapy (NHT) in high-risk cases. Tanislav’s major contributions include a landmark monocentric serial analysis of 500 consecutive RARP cases, which demonstrated that elevated prostate volume significantly influences postoperative readmissions and complications (13 citations). He further showed that high BMI complicates intraoperative courses and may lead surgeons to consider alternatives to prostate removal (6 citations). His investigation into NHT revealed that while it may facilitate resection in high-risk patients, its benefits for local tumor control and overall survival remain unclear (3 citations). By systematically analyzing large, single-surgeon cohorts, Tanislav provides evidence-based guidance for patient selection and preoperative planning, helping urologists tailor surgical approaches to individual risk profiles. His work is particularly valuable for surgeons and trainees seeking to reduce complications and improve functional outcomes in robotic prostate cancer surgery.